1. Home
  2. PCOR vs EXAS Comparison

PCOR vs EXAS Comparison

Compare PCOR & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PCOR

Procore Technologies Inc.

HOLD

Current Price

$77.53

Market Cap

12.3B

Sector

Technology

ML Signal

HOLD

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$101.06

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCOR
EXAS
Founded
2003
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.3B
11.0B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
PCOR
EXAS
Price
$77.53
$101.06
Analyst Decision
Buy
Buy
Analyst Count
18
20
Target Price
$83.06
$76.38
AVG Volume (30 Days)
1.3M
10.3M
Earning Date
11-05-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,275,450,000.00
$3,082,033,000.00
Revenue This Year
$16.35
$19.40
Revenue Next Year
$12.09
$13.51
P/E Ratio
N/A
N/A
Revenue Growth
14.94
14.47
52 Week Low
$53.71
$38.81
52 Week High
$88.92
$101.87

Technical Indicators

Market Signals
Indicator
PCOR
EXAS
Relative Strength Index (RSI) 60.44 89.74
Support Level $74.36 $100.98
Resistance Level $76.70 $101.43
Average True Range (ATR) 2.51 2.25
MACD 0.37 0.53
Stochastic Oscillator 92.58 97.74

Price Performance

Historical Comparison
PCOR
EXAS

About PCOR Procore Technologies Inc.

Procore Technologies Inc is a cloud-based construction management software company. It generates revenue through subscriptions for access to its software products. The company's products include Design Coordination, BIM, Field Productivity, Project Financials, Invoice Management, Portfolio Financials, Capital Planning, Accounting Integrations, and Analytics. The software products are hosted on its cloud-based SaaS construction management platform. Subscriptions are sold for a fixed fee and revenue is recognized ratably over the term of the subscription.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: